Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,778 | 897 | 98.8% |
| Education | $164.15 | 4 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,502 | 102 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,389 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,251 | 92 | $0 (2024) |
| Novo Nordisk Inc | $1,230 | 84 | $0 (2024) |
| PFIZER INC. | $932.59 | 94 | $0 (2024) |
| Astellas Pharma US Inc | $650.66 | 24 | $0 (2024) |
| Amgen Inc. | $634.62 | 43 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $584.25 | 41 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $427.24 | 39 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $425.84 | 28 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,830 | 91 | ABBVIE INC. ($405.90) |
| 2023 | $1,619 | 101 | ABBVIE INC. ($369.85) |
| 2022 | $1,788 | 109 | ABBVIE INC. ($258.37) |
| 2021 | $2,018 | 129 | Esperion Therapeutics, Inc. ($278.21) |
| 2020 | $1,744 | 106 | AstraZeneca Pharmaceuticals LP ($260.94) |
| 2019 | $1,423 | 114 | Amgen Inc. ($179.81) |
| 2018 | $1,624 | 120 | AstraZeneca Pharmaceuticals LP ($254.39) |
| 2017 | $1,897 | 131 | Merck Sharp & Dohme Corporation ($269.35) |
All Payment Transactions
901 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Biological | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Oncology | ||||||
| 11/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: VACCINES | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $109.73 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.74 | General |
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $110.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Diabetes Care | ||||||
| 08/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 480 | 672 | $112,619 | $32,337 |
| 2022 | 13 | 483 | 693 | $107,988 | $26,981 |
| 2021 | 10 | 509 | 720 | $105,070 | $41,399 |
| 2020 | 12 | 497 | 697 | $98,296 | $34,617 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 291 | $52,380 | $12,906 | 24.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $7,350 | $3,960 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 85 | $11,475 | $3,394 | 29.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 46 | 46 | $5,060 | $3,158 | 62.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 80 | 80 | $22,000 | $3,091 | 14.0% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 13 | 13 | $3,757 | $1,670 | 44.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 50 | $1,900 | $1,373 | 72.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $3,705 | $1,091 | 29.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 14 | 14 | $1,260 | $533.68 | 42.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $532.00 | $400.40 | 75.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 40 | $2,000 | $395.04 | 19.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 12 | $1,200 | $363.84 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 290 | $51,402 | $12,543 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 110 | $14,226 | $4,334 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 82 | 82 | $22,289 | $2,697 | 12.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 37 | 37 | $4,070 | $2,526 | 62.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 43 | $1,634 | $1,160 | 71.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 14 | $6,315 | $879.15 | 13.9% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 16 | 16 | $1,440 | $574.29 | 39.9% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 14 | 15 | $1,350 | $537.92 | 39.8% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 15 | 15 | $1,350 | $534.60 | 39.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 14 | 14 | $1,334 | $427.89 | 32.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $456.00 | $325.77 | 71.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 32 | $1,600 | $322.60 | 20.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 13 | $522.00 | $118.14 | 22.6% |
About Dr. Melonie Proctor, DO
Dr. Melonie Proctor, DO is a Family Medicine healthcare provider based in Union, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2009. The National Provider Identifier (NPI) number assigned to this provider is 1205075116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melonie Proctor, DO has received a total of $13,943 in payments from pharmaceutical and medical device companies, with $1,830 received in 2024. These payments were reported across 901 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($13,778).
As a Medicare-enrolled provider, Proctor has provided services to 1,969 Medicare beneficiaries, totaling 2,782 services with total Medicare billing of $135,334. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Union, KY
- Active Since 02/17/2009
- Last Updated 03/09/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1205075116
Products in Payments
- VRAYLAR (Drug) $919.18
- FARXIGA (Drug) $906.15
- TRELEGY ELLIPTA (Drug) $656.07
- NURTEC ODT (Drug) $455.43
- UBRELVY (Drug) $416.89
- Ozempic (Drug) $414.58
- JARDIANCE (Drug) $366.62
- CHANTIX (Drug) $295.43
- NEXLIZET (Drug) $230.50
- Veozah (Drug) $229.01
- XARELTO (Drug) $227.52
- SYMBICORT (Drug) $225.51
- FREESTYLE LIBRE 2 (Device) $212.80
- Vascepa (Drug) $210.87
- GEMTESA (Drug) $205.02
- Otezla (Drug) $186.18
- SHINGRIX (Biological) $182.07
- TOUJEO (Drug) $179.83
- MYRBETRIQ (Drug) $178.24
- Aimovig (Biological) $170.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Union
Vincent Codella, Do, DO
Family Medicine — Payments: $11,857
Dr. Brian Walters, Md, MD
Family Medicine — Payments: $7,966
Dr. Corey Gallus, D.o, D.O
Family Medicine — Payments: $7,043
Dr. Jamie Borgmann, Md, MD
Family Medicine — Payments: $6,904
Michael Richardson, M.d, M.D
Family Medicine — Payments: $4,260
Dr. Craig Sanders, Do, DO
Family Medicine — Payments: $3,568